Caris Life Sciences, Inc. Common Stock (CAI) is a Healthcare · Biotechnology company listed on NASDAQ. Price $30.01 (-2.94%), Market cap $4.11B, 52-week low–high $14.55 ~ $39.30.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect,
Financial statements, price targets, institutional (13F) holdings and related news for Caris Life Sciences, Inc. Common Stock are updated in real time on BlackAll Trade.
Caris Life Sciences, Inc. Common Stock trades at $30.01 (-2.94%). Real-time quotes and charts are available on BlackAll Trade.
Caris Life Sciences, Inc. Common Stock has a market cap of about $4.11B.
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to trans